High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer
published in: PLOS One
date of publication: 2012
language: English
main subject: transcriptome, prostate cancer
Cites articles 64
- 2011-02-04
Date
Title
Article - wd:Q28480861